92 stories found
An article examines the recent pullback in UnitedHealth Group (UNH) stock, posing the question of whether it represents a temporary market glitch or a more serious warning sign for investors. The analysis delves into potential factors influencing the stock's performance.
An investor lawsuit claims that UnitedHealth Group knowingly overlooked significant governance and cybersecurity vulnerabilities for several years.
UnitedHealth Group (UNH) is once again drawing attention from investors, indicating renewed interest in the healthcare giant.
An analysis suggests that despite beating estimates, UnitedHealth Group Incorporated (UNH) and Intuitive Surgical, Inc. (ISRG) stocks may not be performing as expected. The article explores reasons why exceeding financial forecasts isn't always enough for positive market reaction.
New analyst reports have been released for UnitedHealth Group Inc. and Citizens Financial Group Inc. These reports provide detailed financial analysis and insights into the performance and outlook of both companies.
UnitedHealth Group reported strong Q2 earnings, surpassing both top-line and bottom-line estimates, with profits reaching $5.4 billion as costs eased. The company subsequently raised its full-year and FY2026 earnings per share outlook, leading to a rally in its stock.
An analysis explores whether UnitedHealth Group stock is a favorable buy ahead of a specific date, July 16.
An article provides an analysis for investors considering whether to purchase shares of UnitedHealth Group Incorporated (UNH). It likely examines the company's performance and market outlook.
Articles analyze whether UnitedHealth Group Incorporated (UNH) and Vir Biotechnology, Inc. (VIR) are good stocks to buy now. They delve into the investment prospects and current market standing of both companies.
UnitedHealth Group has announced a 5% increase in its dividend, prompting analysis on the potential investment appeal of UNH stock.
An analysis questions whether UnitedHealth Group (UNH) stock is currently outperforming the broader healthcare sector.
UnitedHealth Group is poised to break a streak of six consecutive sessions of losses, signaling a potential rebound for the healthcare giant's stock.
Warren Buffett's Berkshire Hathaway has sold its entire stake in UnitedHealth Group, causing the health insurer's stock to slide. Concurrently, Berkshire Hathaway reportedly returned to investing in department stores, including Macy's.
Warren Buffett's Berkshire Hathaway has confirmed the complete sale of its stake in UnitedHealth Group, causing the health insurer's stock to slide. The conglomerate also reportedly returned to investing in department stores, including Macy's.
An article provides an analysis on whether UnitedHealth Group Incorporated (UNH) is a good stock to buy now, discussing its investment potential.
UnitedHealth Group (UNH) is seen as an attractive investment for 'safe investors' due to its resilience stemming from vertical integration.
UnitedHealth Group Incorporated (UNH) has launched a broad rural health initiative aimed at strengthening healthcare access and services in underserved communities.
UnitedHealth Group's stock has seen a significant boost as Wall Street firms, including Argus, upgraded their ratings and raised price targets following the company's first-quarter earnings that far exceeded expectations.
UnitedHealth Group Incorporated has provided a summary of its earnings call for the first quarter of 2026.
An article suggests that UnitedHealth Group (UNH) shareholders could be looking at a healthy rebound in the near future.
UnitedHealth Group's stock has seen a significant increase following the announcement of strong earnings and an improved financial outlook for the company.
Analysts are evaluating the potential movement of UnitedHealth Group's stock following its upcoming earnings report.
A patient opportunity equity strategy is holding firm on its positive investment thesis regarding UnitedHealth Group (UNH).
UnitedHealth Group (UNH) stock is poised to break its 100-day moving average following updates to the CMS 2027 rates, prompting analysis on whether to invest.
A daily market report highlights the biggest stock movers on Tuesday, featuring companies such as Humana (HUM) and UnitedHealth Group (UNH) among others.
Billionaire Ken Griffin has reportedly identified UnitedHealth Group (UNH) as a top healthcare stock. The article discusses whether UNH is the best investment in the sector.
UnitedHealth Group (UNH) has introduced 'Avery', an artificial intelligence companion, marking a new development in the company's technology offerings.
UnitedHealth Group has initiated a mixed shelf offering, a financial move that allows the company to issue various types of securities over time.
An analysis explores the potential future trajectory and strategic direction of UnitedHealth Group Incorporated (UNH).
An article investigates the reasons behind the performance of UnitedHealth Group's stock, exploring potential issues or factors affecting its valuation.
The chief of UnitedHealth Group reportedly made private side bets on healthcare startups, raising questions about potential conflicts of interest.
Several Purpose ETFs, including the Purpose Global Flexible Credit Fund, Purpose Premium Yield Fund, and Purpose Monthly Income ETF, have declared their latest monthly dividends. These declarations cover a range of investment strategies.
An analysis explores whether Wall Street analysts hold a bullish or bearish outlook on UnitedHealth Group stock.
UnitedHealth Group is experiencing a recovery in its stock, moving from being overlooked to gaining recognition among investors.
Analysts reportedly focused on specific recurring issues and questions when grilling UnitedHealth Group during its recent earnings call, indicating areas of concern or interest for investors.
Several companies, including Consolidated Edison, Valero Energy, Carriage, and Avient, declared dividends. Meanwhile, Abbott Laboratories and UnitedHealth Group reported stronger-than-expected Q2 results, leading both to raise their 2026 earnings outlooks.
An article provides critical insights into UnitedHealth Group (UNH) stock, suggesting investors should avoid purchasing it based on current market conditions.
Several financial analysts have raised their price targets for various technology and healthcare stocks, including Lam Research, UnitedHealth Group, and Advanced Micro Devices. This reflects optimism about chip equipment spending and multi-year manufacturing investments.
JPMorgan has increased its price target for UnitedHealth Group (UNH), signaling a positive outlook on the company's financial performance and market value.
The article discusses whether UnitedHealth Group (UNH) stock can maintain its recent 40% rally.
UnitedHealth Group's shares saw gains following an upgrade from Bank of America, indicating positive market sentiment and analyst confidence in the healthcare giant.
An analysis explores whether UnitedHealth Group Incorporated (UNH) is considered one of the best medical stocks for investment, particularly among billionaire investors.
UnitedHealth Group (UNH) and Walmart (WMT) have been identified by hedge funds as high-quality stocks to consider for investment. Both companies are recognized for their strong market positions and financial performance.
UnitedHealth Group's stock experienced a decline following the news that Berkshire Hathaway had sold its stake in the health insurer.
An opinion piece suggests that investors should consider increasing their holdings in UnitedHealth Group stock, indicating a favorable view of its investment potential.
Morgan Stanley has revised its stock price target for UnitedHealth Group (UNH) after the company released its latest earnings report.
Financial analyst Jim Cramer has advised investors to buy UnitedHealth Group stock, suggesting that historical trends support his recommendation.
Investors Joe Terranova and Stephen Weiss shared their reasons for buying Netflix stock after its earnings pullback and made a bull case for UnitedHealth Group stock on "Halftime Report."
New analyst reports have been issued, providing detailed financial analysis and outlooks for Thomson-Reuters Corp, Unitedhealth Group Inc, and Genuine Parts Co. These reports offer insights into the performance and prospects of the respective companies.
UnitedHealth Group has released highlights from its first-quarter earnings call, detailing the company's financial performance.
A surge in UnitedHealth Group (UNH) stock has brought attention to exchange-traded funds (ETFs) with significant exposure to the company's shares.
Managed care stocks experienced a jump after UnitedHealth Group (UNH) released its first-quarter report, with an analysis highlighting nine top Quant-rated names in the sector.
UnitedHealth Group is reportedly facing a significant reckoning, indicating potential challenges or investigations ahead for the healthcare giant.
Bank of America (BofA) has increased its price target for UnitedHealth Group to $337, up from $315. The revised target indicates a more optimistic outlook from the bank.
Shares of UnitedHealth Group and Humana Inc. rocketed by 11% and 9% respectively, following a Medicare Advantage rate decision. The decision reportedly alleviated regulatory fears among investors.
UnitedHealth Group (UNH) has been upgraded by analysts, citing potential upside to its earnings estimates.
UnitedHealth Group (UNH) experienced significant pressure in 2025 due to self-inflicted operational issues, impacting its performance.
The UnitedHealth Group (UHN) Yield Shares Purpose ETF - ETF Series has announced a dividend declaration of CAD 0.15 for its shareholders.
An article discusses the growth potential of UnitedHealth Group (UNH) and prompts investors to consider its future prospects.
UnitedHealth Group has reportedly capped employee pay raises at 2%, according to Bloomberg News.
UnitedHealth Group is encountering new challenges, prompting investors to assess the implications for their holdings.
The CEO of UnitedHealth Group reportedly made private side bets on healthcare startups, raising questions about potential conflicts of interest.
This article evaluates UnitedHealth Group (UNH) and Eli Lilly and Company (LLY) to assess which healthcare stock offers a more attractive dividend for investors.
An analysis explores the potential for UnitedHealth Group (UNH) to see substantial stock upside as its Medicare profits are expected to recover.
UnitedHealth Group's stock has seen a significant rally since Berkshire Hathaway, led by Warren Buffett and Greg Abel, divested its stake in the company. This raises questions about whether Berkshire Hathaway's decision to sell was premature.
Analysts are evaluating UnitedHealth Group's stock trajectory, with discussions focusing on whether its share price could reach the $500 mark.
UnitedHealth Group reported $5.48 billion in Q2 profits and subsequently raised its 2026 profit forecast, attributing the success to lower medical costs, robust Optum growth, and strategic AI investments.
Major health insurance companies, including UnitedHealth Group, CVS Health, and Cigna, are taking legal action against states that have enacted new laws targeting their pharmacy businesses.
An overview of what to expect from UnitedHealth Group's second-quarter 2026 earnings report is provided.
UnitedHealth Group's stock has reached a 52-week high, prompting questions among investors about whether it is still a good time to buy this soaring stock.
UnitedHealth Group's stock experienced a jump after receiving an upgrade from Bank of America, which noted the company's evolving role beyond just an insurance provider.
UnitedHealth Group is reportedly impacted by concerns surrounding Medicare reimbursement policies, which could affect its financial operations.
UnitedHealth Group (UNH) is listed among the 12 best dividend stocks for investment, according to an analysis of hedge fund portfolios. This highlights its appeal to institutional investors seeking stable returns.
UnitedHealth Group is experiencing gains as the managed care sector continues to outgrow the broader economy.
UnitedHealth Group's stock experienced a 33% decline as the company faced pressure on its earnings from increasing medical costs and changes in its member mix.
UnitedHealth Group announced better-than-expected first-quarter earnings and increased its financial guidance for the year. The report details the company's performance and future outlook.
Financial analyst Jim Cramer has endorsed UnitedHealth Group (UNH) stock at $354, providing a mathematical rationale to support his recommendation.
An analysis explores what positions UnitedHealth Group (UNH) as a leader in value-based care services.
UnitedHealth Group has indicated that its business turnaround is finally underway, suggesting positive developments for the company.
Several companies, including River Valley Community Bancorp, EQT, Calix, and Hancock Whitney, have released their latest quarterly financial reports. These reports detail their earnings per share (EPS) and revenue performance for the recent period.
Following a recent surge, UnitedHealth Group's stock has moved into overbought territory, prompting questions about the timing for further investment in its turnaround.
UnitedHealth Group's shares surged after the company reported better-than-expected quarterly earnings and subsequently raised its full-year financial outlook.
UnitedHealth Group continues to grapple with a significant $6 billion impact related to Medicare, indicating ongoing financial challenges.
An analyst has increased the price target for UnitedHealth Group (UNH) while maintaining a 'Neutral' rating on the stock.
Health insurance stocks are experiencing a significant surge today, driven by a recent update regarding Medicare policies.
Shares of major health insurance companies, including UnitedHealth Group, CVS, and Humana, are experiencing gains driven by recent news concerning Medicare Advantage.
UnitedHealth Group (UNH) is being analyzed for its potential to generate wealth by 2026, even as its stock has lost nearly half its value in the last year, with one analyst now recommending it as a buy.
UnitedHealth Group has reportedly capped salary increases at 2% as part of a company-wide restructuring initiative.
The Aristotle Growth Equity Fund has made several portfolio adjustments, selling shares in Linde (LIN) and Alexandria Real Estate Equities (ARE) due to market expectations, while investing in DexCom (DXCM) based on its expanding market leadership.
The chief of UnitedHealth Group made private investments in healthcare startups, raising questions about potential conflicts of interest.